Call Us: +44 (0) 1752 753723[email protected]
Lucy Hinchion, Cord Blood infusion for Type 1 Diabetes

Cord blood used to ‘switch off’ type 1 diabetes

Australian toddler Lucy Hinchion is already a medical pioneer. Aged just 20 months, Lucy became the youngest ever recipient of an infusion of her own umbilical cord blood cells to “switch off” type 1 diabetes. How can cord blood treat type 1 diabetes? Cord blood is rich in regulatory...

diabetes cord blood

UF Health diabetes researchers discover a way to expand potent regulatory cells

For parents, storing their newborn baby’s umbilical cord blood is a way to preserve potentially lifesaving cells. Now, a group of University of Florida Health researchers has found a way to expand and preserve certain cord-blood cells as a potential treatment for Type 1 diabetes. The findings involve thymic...

Diabetes type 1 - cord blood treatments

Stem cell transplant findings could lead to personalised type 1 diabetes treatments

A clinical trial has shown promising findings from stem cell transplants in people with type 1 diabetes, with some patients coming off insulin injections for several years. This international research could also lead to better outcomes for more patients who undergo stem cell transplantation, according to senior author Dr...

NSW toddler reinfused with umbilical blood

A toddler from Sydney has become the youngest child in the world to receive her own umbilical cord blood in a study to prevent the onset of Type 1 diabetes. A Sydney toddler whose umbilical cord blood was stored to help treat her sister’s Type 1 diabetes has had...

image of Type 1 diabetes sufferer Chloe and here two sons

A Loxton mother has registered her sons in a world-first Australian study that is hoping to prevent Type 1 diabetes in children

Chloe Docking developed Type 1 diabetes at the age of just eight and has endured a lifetime of insulin injections. Now aged 30, she wants to protect her young sons – Jaxon, 4, and Izzak, 2 – from the same fate. “Because I have it, there’s a chance they...

AstraZeneca, Harvard Stem Cell Institute enter five-year diabetes research collaboration

AstraZeneca has signed a five-year collaboration deal with the Harvard Stem Cell Institute (HSCI), under which the parties will investigate adapting a technique to create human beta cells from stem cells for use in finding new treatments for diabetes. As part of the deal, AstraZeneca will provide funding for...

stem-cells

Stem Cell therapy with drugs rekindles new hope to Diabetes 2 treatment

Canada-based University of British Columbia scientists have shown for the first time that Type 2 diabetes can be tackled with a combination of specially-cultured stems cells and conventional diabetes drugs. The scientists have used stem cells to reverse the type 1 diabetes in mice and hope to apply similar...

An interview with the founder of the Prenatal Classroom

We’ve been working closely with Dr Anastasia Alcock who founded the Prenatal Classroom to provide comprehensive, evidence-based information and support for pregnant women. Here are her views on the challenges facing first-time mums, growing a business and why awareness of cord blood should be higher. 1. Anastasia, what sparked...

Clinical trial to test safety of stem cell-derived therapy for Type 1 diabetes

The first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes has been launched by researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte Inc. The trial will test the safety and efficacy of the drug...